Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FASN | P49327 | 1/20 | 0.49 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.46 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | HPGD | P15428 | 1/20 | 0.41 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.41 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.41 |
| ▸ | CASP1 | P29466 | 1/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.41 |
| ▸ | TAAR1 | Q96RJ0 | 2/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.39 |
| ▸ | HTR2A | P28223 | 1/20 | 0.39 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | LOXL2 | Q9Y4K0 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11687983 | 0.84 | FASN (0.53) | FASNSLC6A2SLC6A4SLC6A3ALDH1A1 | |
| SCHEMBL5172288 | 0.78 | SLC6A2 (0.50) | FASNSLC6A2SLC6A4SLC6A3ALDH1A1 | |
| SCHEMBL1493179 | 0.78 | FASN (0.49) | FASNSLC6A2SLC6A4SLC6A3ALDH1A1 | |
| SCHEMBL5864654 | 0.78 | SLC6A2 (0.50) | FASNSLC6A2SLC6A4SLC6A3ALDH1A1 | |
| SCHEMBL8786930 | 0.78 | SLC6A2 (0.50) | FASNSLC6A2SLC6A4SLC6A3ALDH1A1 | |
| SCHEMBL8200189 | 0.78 | SLC6A2 (0.50) | FASNSLC6A2SLC6A4SLC6A3ALDH1A1 | |
| SCHEMBL11825236 | 0.77 | FASN (0.47) | FASNSLC6A2SLC6A4SLC6A3ALDH1A1 | |
| SCHEMBL5973222 | 0.75 | TDP1 (0.46) | FASNSLC6A2SLC6A4SLC6A3TDP1 | |
| SCHEMBL7545254 | 0.75 | FASN (0.46) | FASNSLC6A2SLC6A4SLC6A3ALDH1A1 | |
| SCHEMBL5973225 | 0.75 | TDP1 (0.46) | FASNSLC6A2SLC6A4SLC6A3TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8217184-B2 | Process for producing optically active cis-silyl olefin oxide compound | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2012-07-10 | — | — | US | disclosed |
| US-20100305338-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE CIS-SILYL OLEFIN OXIDE COMPOUND | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2010-12-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305338-A1 | PROCESS FOR PRODUCING OPTICALLY ACTIVE CIS-SILYL OLEFIN OXIDE COMPOUND | CYP51A1, MSMO1, SQLE | FASN 479/4885SLC6A2 3995/4885SLC6A4 3755/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.